Ocean Biomedical Inc. (OCEA)
0.06
-0.00 (-3.85%)
At close: Mar 21, 2025, 3:59 PM
0.06
0.49%
After-hours: Mar 21, 2025, 07:10 PM EDT
-3.85% (1D)
| Bid | 0.06 |
| Market Cap | 8.59M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -136.14M |
| EPS (ttm) | -0.95 |
| PE Ratio (ttm) | -0.06 |
| Forward PE | -0.37 |
| Analyst | n/a |
| Ask | 0.06 |
| Volume | 11,434,087 |
| Avg. Volume (20D) | 35,503,237 |
| Open | 0.06 |
| Previous Close | 0.06 |
| Day's Range | 0.06 - 0.06 |
| 52-Week Range | 0.05 - 4.68 |
| Beta | 1.41 |
About OCEA
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatm...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 8, 2021
Employees 9
Stock Exchange NASDAQ
Ticker Symbol OCEA
Website http://www.oceanbiomedical.com
1 month ago
-26.33%
Ocean Biomedical shares are trading higher after t...
Unlock content with
Pro Subscription
